ArticleClinical and translational medicine2024
O-GlcNAcylation promotes malignancy and cisplatin resistance of lung cancer by stabilising NRF2.
Yihan Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it